References:
Abel, G. and Czop, J.: "Stimulation of Human Monocyte Beta-glucan Receptors
by Glucan particles induces production of TNF-alpha and IL-I beta," Int.
J. Immunopharmacolol., 14:1363-1373; 1992.
Abel, G. and Czop, J. K.: "Activation of Human Monocyte GM-CSF and TNF-.
alpha. Production by Particulate Yeast Glucan," International Congress
for Infectious Diseases, Montreal Canada (abstract). 1990. Dept. of Medicine,
Harvard Medical School Boston, MA.
Adachi Y., Ohno N., Yacomae, T.: "Preparation and antigen specificity
of an anti-(I-->3)-beta-D-glucan antibody," Bio. Pharm. Bull. 17:1508-1512;
1994.
Adachi Y., Ohno, N., Yacomae, T.: "Bibibitory effect of beta-glucans on
zymosan-mediated hydrogen peroxide production by murine peritoneal macrophages
in vitro," Bio. Pharm. Bull. 16:462-467; 1993.
Adachi Y., Ohno, N., Ohsawa, M., Oikawa, S., Yacomae, T.: "Macrophage
activation in vitro by chemically cross-linked (1--3)-beta-D-glucans,"
Chem. Pharm. Bull. (Tokyo), 38:988-992; 1990. Laboratory of Immunopharmacology
of Microbial Products, Tokyo College of Pharmacy, Japan.
Afio, T., et al: "Isolation of the Candida albicans homologs of function,"
J. Bacteriol 179(7):2363-2372, Nippon Roche Res. Ctr., Kamakura, Japan; 1977.
Ainsworth A.: "A beta-glucan habitable zymosan receptor on channel catfish
neutrophils," Vet. Immunol. Immunopathol 41:141-152; 1994.
Bacon, J., et al: "The Glucan Components of the Cell Wall of Baker's Yeast
(Saccharomyces cerevisiae) Considered in Relation to its Ultrastructure,"
Biochem J. 114:557-567; 1969.
Baird, et al: "Investigation of the Polysaccharides Produced by Extracellular
Glycosyltransferases from Streptococcus Mutans," Chemical Abstracts; Vol.
77, No. 11, P. 242. Abs. No. 72399Z; 1972.
Almdahl, S. M., Bogwald, J., Hoffman, J., Seljelid, R.: "The Effect of
Splenectomy on Escherichia coli sepsis and its treatment with semisoluble aminated
glucan," Scand. J. Gastroenterol 22(3):261-267; 1987.
Almdahl, S. M., Bogwald, J., Hoffman, J., Seljelid, R., Giercksky, K.E.: "Protection
by Aminated Glucan in Experimental Endogenous Peritonitis," Euro. Surg.
Res. 19(2):78-85; 1987.
Almdahl, S. M., Seljelid, R.: "Semisoluble Animated Glucan: long-term
efficacy against an intraperitoneal E. coli challenge and its effect on formation
of abdominal adhesions," Res. Exp. Med. (Berlin) 187(5):369-377; 1987.
Andaluz, E., Guillen, A., Larriba, G.: "Preliminary evidence for a glucan
acceptor in the yeast Candida Albicans," Biochem J., 240:495-502; 1986.
Aono, R., Hammura, M., et al: "Isolation of extra-cellular 28- and 42-kilodalton
beta-1-3-glucanases and comparison of three beta-1,3-glucanases produced by
Bacillus circulans IAM1165," Appl. Environ. Microbiol. 61:122-129; 1995.
Artursson, P. et al: "Macrophage stimulation with some structurally related
polysaccharides," Scand. J. Immunol. 25(3):245-254; 1987.
Babineau, et al: "A Phase H Multicenter, Double-Blind Randomized, Placebo-Controlled
Study of Three Dosages of an Immunomodulator (PGG-Glucan) in High Risk Surgical
Patients", Arch. Surg. 129:12041210. 1994. Dept of Surgery, Deaconess Hospital
Harvard Medical School, Boston, MA.
Babineau, et al: "Randomized Phase YU Trial of a Macrophage Specific Immunomodulator
(PGG-Glucan) in High Risk Surgical Patients", Annals of Surgery; 220:(5):601-609;
1994. Dept of Surgery, Deaconess Hospital Harvard Medical School, Boston MA.
Bacon J., et al: "The Glucan Components of the Cell Wall of Baker's Yeast
(Saccharomyces Cerevisiae) Considered in Relation to Ultrastructure," Chemical
Abstracts, 71:109168; 1991.
Barlin, et al: "Heterogeneity of Molecular Phagocytes," Forster &
Landy, Eds., Academic Press, New York, pp. 243-252. 1981.
Benach, J. L., et al: "Glucan as an adjuvant for a murine Babesia micro
immunization trial" Infection and Immunity, 35(3):947-951; 1982.
Beta(1-3)glucan Activity in Mice: "Intraperitoneal and Oral Applications."
Baylor College of Medicine. Research Summary; 1989.
Beta(1-3)glucan: "11-1 Cytokine Release after Oral Application in Mice."
Baylor College of Medicine. Research Report. 1994.
Bogwald, J., Johnson, E., Hoffman, J., Seljelid, R.: "Lysosomal Glycosidase
in Mouse Peritoneal Macrophages Stimulated in Vitro With Soluble and Insoluble
Glucans." J. Leucyte Biol.; 35:357-371; 1984.
Bogwald, J., Johnson, E., Seljelid, R.: "The Cytotoxic Effect of Mouse
Macrophages Stimulated in Vitro by a Beta-1,3-D-Glucan from Yeast Cell Walls."
Scand. J. Immunol. 15:297-304; 1982. Institute of Med. Bio., U. of Tromso, Norway.
Bone, R. C.: "Gram-negative sepis." Background, clinical features
and intervention. Chest 100:802-808; 1991.
Bomford and Moreno: "Mechanisms of the Anti-Tumor Effect of Glucans and
Fructosans: A Comparison with C. Parrvum" Br. J. Cancer 36:4148; 1977.
Boone, C., Sdicu, A., Laroche, M., Bussey, H.: "Isolation from Candida
albicans of a functional homolog of the Saccharomyces cerevisiae KREI Gene,
which is involved in cell wall beta-glucan synthesis," J. Bacteriol 173
(21):6859-6864; 1991.
Boone, C., Sommer, S. S., Hensel, A., Bussey, H.: "Yeast KRE genes provide
evidence for a pathway of cell wall beta-glucan assembly," J. Cell. Biol.
110:1833-1843; 1990.
Borriss, et al: "Molecular cloning of a gene coding for thermostable betaglucanase
from Bacillus macerns," J. Basic Microbiol. 28:3-10; 1988.
Borriss, et al: "Expressions in Escherichia coli of a cloned beta.-glucanase
gene from Bacillus Amyloliquefaciens," Appl. Microbiol. Biotechnology 22:63-71;
1985.
Borriss, et al: "Beta-1,3-1,4-glucanase in sporeforming microorganisms.
V. The efficiency of beta-glucanase in reducing the viscosity of wort,"
Zbl. Bakt II, Abt. 136:324-329; 1981.
Bousquet, M., Escoula, L., et al: "Immunopharmacologic study in mice of
2 beta-1,3, beta-1,6 polysaccharides (scleroglucan and PSAT) on the activation
of macrophages and T lymphocytes," Ann Rech Vet 20:165173; 1989. Station
of Pharmacologie-Toxicologie, INRA, Toulouse, France.
Bousquet M., Escoula, L., Pippy, B., Besssieres, M. K., Chavant, L., Seguela,
J. P.: "Enhancement of Resistance of mice Toxoplasma gondi by 2 polysaccharides
beta(1-3)glucan 1-3, beta(1-3)glucan 1-6 (PSAT and Scleroglucan)," Ann
Parasitol Hum. Comp., 163(6):398-409; 1988.
Bowers, G. J., Patchen, M. L., et al: "Glucan enhances survival in an
intraabdominal infection model," J. Surg. Res. 47(2):183-188; 1989.
Broach, J. R., Pringle, J. R., Jones, E. W.: "The Molecular and Cellular
Biology of the Yeast Saccharomyces Cerevisiae," Genome Dynamics, Protein
Synthesis, and Energetics; Cold Springs Harbor Laboratory Press, Cold Spring
Harbor, New York; 1991.
Browder, W., Williams, D., Pletus H., et al: "Beneficial Effect of Enhanced
Macrophage Function in the Trauma Patients," Ann. Surg. Vol. 211:605613;
1990. Dept. of Surg. and Physiol. Tulane Univ. Sch. of Med., LA and Istituto
Di Chirurgia D'Urgenza, Univ. of Torino, Torino, Italy.
Browder, I. W., Sherwood, E., Williams, D., Jones, E., McNamee R., DiLuzio
N.: Am. J. Surg. 1153(1):25-33; 1987.
Browder, W., Williams, D., Sherwood, E., McNamee, R., Jones, E., DiLuzio N.:
"Synergistic effect of nonspecific immunostimulation and antibiotics in
experimental peritonitis," Surgery, 102(2):206-214; 1987.
Browder, W., et al: "Modification of Post-Operative C. Albicas Sepis by
Glucan Immunostimulation," Int. J. Immunopharmac. 6:19-26; 1984. Dept.
of Surg. and Physiol. Tulane Univ. Sch. of Med., IA.
Browder, W., et al: "Protective Effect of Nonspecific Immunostimulation
in Post Splenectomy Sepis," J. Surg. Res. 35:474-479; 1983. Dept. of Surg.
and Physiol. Tulane Univ. Sch. of Med., LA.
Browder, W.: "Survey of Immunological Research," 2:229-301; 1983.
Browder, W., et al: "Immunomodulation by Microbiobal Products and Related
Synthetic Compound," Yamamura, et al, Eds. Excerpta Medica, Amsterdam,
Pgs. 354-357; 1982.
Browder W., et. al.” Beneficial effect of enhanced macrophage function
in the trauma patient,” Ann Surg, May,1990. Babineau TJ, et. al. “A
phase II multicenter, double blind, randomized, placebo-controlled study of
three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients,”Arch
Surg. 1994 Nov. 1994.
Brown G D, Gordon S; "Immune recognition. A new receptor for beta-glucans."
Sir William Dunn School of Pathology, University of Oxford, Nature 6;413(6851):36-7.
Sep 2001.
Brown, J. L., et al: "A mutational analysis of killer toxin resistance
in Saccharomyces cerevisiae identifies new genes involved in cell wall (1->6)-beta-glucan
synthesis," Genetics 133(4) 837-849; 1993.
Buddle, B. M., et al: "Protective effect of glucan against experimentally
induced staphylococcal mastitis in ewes," Vet. Microbiol. 16(l):67-76;
1988.
Burgaleta, C., Goide, D. W.: "Increased granulopoiesis and macrophage
production in glucan-treated mice," Chirigos, M.A., Ed. Immune Modulation
and Control of Neoplosia by Adjuvant Therapy, New York, Raven Press, 195-219;
1978.
Burgaleta, C., Territo, M. C., Quan, C. G., Goide, D.W.: "Glucan activated
macrophages: functional characteristics and surface morphology" J. Reticuloendothel
Soc. 23:195-204; 1978.
Burgaleta, C. and Golde, D. W.: "Effect of Glucan on Granulopoiesis and
Macrophage Genesis in Mice." Cancer Research, 37:1739-1742; 1977.
Cain, J. A., Newman, S. L., Ross, G. D.: "Role of complement receptor
type three and serum opsonins in the neutrophil response to yeast," Complement
4:75-86; 1987.
Carrow, D. J.: "Beta-1,3-glucan as a Primary Immune Activator," Townsend
Letter; 1996.
Cerenius, L., Liang, Z., Duvie, B., et al: "Structure and biological activity
of a 1,3 beta-D-glucan-binding protein in crustacean blood," J. Biol. Chem.
269:29462-29467; 1994.
Chen Y. H., Riby, Y., Srivastava, P., Bartholomew, J., Denison, M., Bjeldanes
L.: "Regulation of CYP1A1 by Indolo{3,2-b} Carbazole in Murine Hepatoma
Cells," J. Biol. Chem., 270(38):22548-55; 1995.
Cheung NK, Modak S, Vickers A, Knuckles B; "Orally administered beta-glucans
enhance anti-tumor effects of monoclonal antibodies," Department of Pediatrics,
Memorial Sloan-Kettering Cancer Center, Cancer Immunology, Immunotherapy ;51(10):557-64.
Dec 2002.
Chihara, G., et al.: "Lentinan as a Host Defense Potentiator (BPD),"
Int. J. Immunotherapy; V(4):145-154; 1989.
Chihara G., Rivista: "Di Immunology," Ed. Immunofarm; 5:(2):85-97;
1983.
Chirigos, A., et al: "Cancer Research," 38:1085-1091; 1978.
Cisreros R. L., Gibson F. C. 3, Tzianabos, A. O.: "Passive transfer of
poly-(1-6)beta-glucotriosyl-(1-3)-beta glucopyranose glucan protection against
lethal infection in an animal model of intra-abdominal sepsis," Infect
Immun. 64(6):2201-2205; 1996. Charming Laboratory, Brigham and Women's Hospital
Boston, MA.
Clark, A. E., Stone, B. A.: "Beta-glucan hydrolases from Aspergillus niger."
Isolation of a beta-(1-4)-glucan hydrolase and some properties of the beta.
Compton R, Williams D, Browder W; “The beneficial effect of enhanced
macrophage function on the healing of bowel anastomoses,” Am Surg, 62:1,14-8.
Jan 1996.
Cook, J. A., et al: "Infection and Immunity" 40(3):1038-1043; 1983.
Cook, J. A., et al: "Immunomodulation of Protozoan Diseases." Immunolg.
Res., 2:243-245; 1983.
Cook, J. A., et al: "Protective Effect of Glucan against Visceral Leishmaniasis
in Hamsters." Immun., 37:1261-1269; 1982.
Cook, J. A., et al: "Viscereal Leigimaniasis in Mice: Protective Effect
of Glucan." J. Reticuloendothel; Soc. 27:567-573; 1980.
Cross, C. E., Bancroft, G. J.: "Ingestion of acapsular Cryptococcus neoformans
occurs via mannose and beta-glucan receptors, resulting in cytokine production
and increased phagocytosis of the encapsulated form" Infect Immun. 63:2604-2611;
1995. Dept. Clin. Sci., London School of Hygiene and Trop. Med., England.
Crueger, et al, Biotechnology: "A Textbook of Industrial Microbiology"
2nd Ed., Pgs. 9-58; 1989.
Czop, K., Janusz, M.: "Derivativized Polysaccharides with Biologic Activity,
Method of their isolation, and uses therefore," U.S. Patent 5 05 75 03,
Issued Oct 15, 1991.
Czop, J. K., Kay, J.: "Isolation and Characterization of B-glucan Receptors
on Human Mononuclear Phagocytes" J. Exp. Medicine, V. 173:1511-1520; 1991,
Dept. of Med., Harvard Med. Sch., Boston, MA.
Czop, J. K., Gurish, M. F., Kadish, J. L.: "Production and Isolation of
Rabbit Anti-idiotypic Antibodies Directed Against the Human Monocyte Receptor
for Yeast B-glucans." Journal of Immunology; 145:995-1001; 1990. Dept.
of Med., Harvard Med. Sch., Boston, MA.
Czop, J. K., Puglisi, A. V., Miorandi, D. Z., Austen, K. F.: "Pertubation
of beta-glucan receptors on human neutrophils initiates phagocytosis and leukotriene
B4 production," J. Immuno. 141:3170-3176; 1988.
Czop, Joyce K.: "The Role of beta-glucan Receptors on Blood and tissue
Leukocytes in Phagocytosis and Metabolic Activation." Pathology and Immunopathology
Research; 5:286-296; 1986.
Czop, J. K, Austen, K. F.: "A B-glucan Inhabitable Receptor on Human Monocytes:
Its Identity with the Phagocytic Receptor for Particular Activators of the Alternative
Complement Pathway." Journal of Immunology 134:2588-2593; 1985.
Czop, J. K., Austen, K. F.: "Properties of glycans that activate the human
alternative complement pathway and interact with the human monocyte beta-glucan
receptor." J. Immunol. 135:3388-3393; 1985.
Czop, J. K., Austen, K. F.: "A beta-glucan inhibitable receptor on human
monocytes: its identity with the phagocytic receptor for particulate activators
of the alternative complement pathway," J. Immunol. 134(4):2588-2593; 1985.
Czop, J. K., Austen, K.F.: "Generation of leukotrienes by human monocytes
upon stimulation of their beta-glucan receptor during phagocytosis," Proc.
National Academy of Science, USA. 82:2751-2755; 1985.
Czop, J. K., Dadish, J. L., Zepf, D. M., Austen, K. F.: "Identification
with monoclonal antibodies of different regions of human plasma fibronectin,
including that which interacts with human monocyte fibronectin receptors."
Immunology. 54:407; 1985.
Czop, J. K., McGowan, S. E., Center, D. M.: "Opsonin-independent phagocytosis
by human alveolar macrophages: augmentation by human plasma fibronectin."
Am. Rev. Respir. Dis., 125:607; 1982.
Czop, J. K., Fearon, D. T., Austen, K. F.: "Opsonin-independent phagocytosis
of activators of the alternative complement pathway by human monocytes"
J. Immunol.; 120:1,132; 1978.
Daum, T., Rohrbach, M. S.: "Zymosan induces selective release of arachidonic
acid from rabbit alveolar macrophages via stimulation of a beta-glucan receptor,"
FEBS Letter 309:119-122; 1992.
Deimann, W., Fahimi, H.D.: "The Appearance of Transition Forms Between
Monocytes and Kupffer Cells in the Liver of Rats Treated with Glucan,"
J. Exp. Med., Pgs. 883-897; 1979. Dept. of Anatomy, Univ. of Heidelberg, Germany.
Deslanders, et al: "Triple-Helical Structure (1,3)-.beta.-D-Glucans."
Macromolecules 13:1466-1471; 1980.
Deville, et al: "Le-Beta 1,3-Glucan et Autres Inimunomodulateurs dans
L'Unfection lepresis Experimental Chez La Souris," Acta. Leprologica. 77/76:273-281;
1979.
DiLuzio, N. R.: "Soluble phosphorylated glucan" U.S. Patent 487777,
Issued Oct. 31, 1989.
DiLuzio, N. R., Williams D. L., Browder, I. W.: "Soluble phosphorylated
glucan: methods and compositions for treatment of neoplastic diseases."
U.S. Patent 4818752; 1989.
DiLuzio, N. R.: "Soluble phosphorylated glucan" U.S. Patent 4739046;
1988.
DiLuzio, N. R., Williams, D. L.: " The Roll of Glucan in the Prevention
and Modification of Microparasitic Diseases." Chemical Regulation of Immunology
in Veterinary Medicine, Alan R. Liss, Inc.; Pgs. 443-456; 1984.
DiLuzio, N. R.: "Inimunopharmacology of glucan: a broad spectrum enhancer
of host defense mechanisms." Trends in Pharmacology. SCI., 4:344-347 "The
broad spectrum of immunopharmacological activities of glucan includes not only
the modification of certain bacterial fungal viral and parasitic infections,
but also inhibition of tumor growth."
DiLuzio, N. R., Williams, D. L., et. al.: "Comparative evaluation of the
tumor inhibitory and antibacterial activity of solubilized and particulate glucan,"
Recent Results Cancer Research 75:165-172. 1980.
DiLuzio, N. R., Williams, D.L.: "Enhancement of host susceptibility to
Staphylococcus aureus infection by chronic ethanol ingestion-modification by
glucan immunostimulation," Alcohol Clin. Exp. Res. 4(3):254-260; 1980.
DiLuzio, N. R.: "Advances in Immunopharmacology," Pergamon Press
Oxford, New York, Pgs. 477-484; 1980.
DiLuzio, N. R., Williams, D. L., et al: "ConVarative tumor-inhibotory
and antibacterial activity of soluble and particulate glucan," Int. J.
Cancer, 24(6):773-779; 1979.
DiLuzio, N. R., Kokosbis, P. L.: "Serum lysozyme: An index of macrophage
function." J. Reticuloendothel, Soc. 25:85-99; 1979.
DiLuzio, N. R., Williams, D. L.: "Glucan-Induced Modification of the Increases
Susceptibility of Cyclophosphamide-Treated Mice to Staphylococcus Aureus Infection."
Cancer Immunol. 6:379; 1979.
DiLuzio, N. R., Williams, D. L.: "Protective Effect of Glucan against
Systemic Staphylococcus aureus septicemia in normal and leukemic mice,"
Infect. Immun. 20(3):804-810; 1978. Dept. of Physiol., Tulane Univ., LA.
DiLuzio, N. R.: "Cells and Other Liver Sinusoidal Cells." Wisse and
Knook, Eds., Elsevier, Amsterdam, Pgs. 397-406; 1977.
DiLuzio, N. R., et al: "The Macrophage and Cancer," James, et al,
Eds., Edinburgh Univer. Med. Pres., Pgs. 181-201; 1977.
DiLuzio N. R., et al: "The Employment of Glucan and Glucan Activated Macrophages
in the Enhancement of Host Resistance to Malignancies in Experimental Animals,"
in The Macrophage in Neoplasia; Academic Press, Inc. New York, Pgs. 181-198;
1976.
DiLuzio, N. R., Morrow R. S.: "Comparative behavior of soluble and particulated
antigens and inert colloids in reticuloendotheilial-stimulated or depressed
mice" J. Reticuloendothel Soc. 9:273-287; 1971.
DiLuzio, N. R., et al: "Evaluation of the Mechanism of Glucan-Induced
Stimulation of the Reticuloendothelial System." J. Reticuloendothelial
Soc., Soc.7:731-742; 1970.
Di Renzo, L., Yefenot E., Klein," E: "The Function of Human NK cells
is enhanced by B-Glucan, a ligand of CR3 (CDI lb/CDI 8)." Euro. J. Immunol.,
21:1755-1758; 1991.
Doita, M., Rasmussen, L.T., Seljelid, R., Lipsky, P.E.: "Effect of soluble
aminated beta- 1,3-D-polyglucose on human monocytes: stimulation of cytokine
and prostaglandin E2 production but not antigen-presenting function." J.
Leukoc Biol., 49(4):342-351; 1991.
Donzis, Byron A.: "Substantially purified beta (1,3) finely ground yeast
cell wall glucan composition with dermatological and nutritional uses."
U.S. Patent 5576015; 1996.
Donzis, Byron A.: "Solubilized yeast glucan" U.S. Patent 5519009;
1996.
Donzis, Byron A.: "Photoprotective composition containing yeast extract"
U.S. Patent 5397773; 1995.
Donzis, Byron A.: "Method of revitalizing skin by applying topically water
insoluble glucan" U.S. Patent 5223491; 1993.
Donzis, Byron A.: "Method and Composition for Treating Hyperlipemia."
U.S. Patent 4,891,220; 1990.
Donzis, Byron A.: "Process For The Preparation of Immunopotentiating Agents
From Components Of Yeast Cell Wall Material." U.S. Patent 4,138,479; 1979.
Donzis, Byron A., Joyce Czop: "Metodo Para Revitalizar La Piel Aplicando,
Topicamente, Glucano Insoluble En Agua." Mexico Patent 183058, 1990.
Donzis, Byron A.: "Substantiallly Purified Beta (1,3) Finely Ground Yeast
Cell Wall Glucan Composition with Dermatological and Nutritional Uses."
U.S. Patent 5,702,719, 1997.
Donzis, Byron A.: "Substantiallly Purified Beta (1,3) Finely Ground Yeast
Cell Wall Glucan Composition with Dermatological and Nutritional Uses."
U.S. Patent 5,705,184, 1998.
Donzis, Byron A., Joyce Czop: "Extrait De Levure Insoluble, Insoluble
Yeast Extract," Canadian Patent 2,072,145, 1990.
Drovanti, A., Bignamini, A., Rovatyi, A.: "Therapeutic Activity of Oral
Glucosamine Sulfate in Osteoarthritis: A Placebo-controlled Double-blind."
Duan, X., Ackerly, M., et al: "Evidence for involvement of beta-glucan
binding cell surface lectins." Cell. Immunol. 157:393-402; 1994.
Duvic, B., Soderhaff, K: "Purification and partial characterization of
a beta1,3-glucan-binding protein membrane receptor from blood cells of the crayfish
Pacifastacus leniusculus," Eur J. Biochem, 207:223-228; 1992.
Enhanced Healing of Decubitus Ulcers by Topical Application of Particulate
Glucan. Tulane University School of Medicine, Research Summary; 1984.
Ebisu, et al: "Studies on the Structure of Polysaccharides (Glucans and
Fructans) Produced by Cariogenic Streptocci and on an Enzyme Hydrolyzing the
Insoluble Glucan 1. Structural Studies of Insoluble Glucan, Soluble Glucan,
and Fructans," Chemical Abstracts; 38:374-381; 1976.
Elmets, et al: J. Investigative Dermatol., 79:340-345; 1967.
Elstad, M.R., Parker, C. J. et al: "CDI lb/CDI 8 integrin and a beta-glucan
receptor act in concert to induce the synthesis of platelet-activating factor
by monocytes," J. Immunol. 152:220-230; 1994.
Ehrke, et al: Int'l J. Immunopharm; 5:34-42; 1992
Engstad, R. E., Robertsen, B.: "Recognition of yeast cell wall glucan
by Atlantic salmon (Sabno salar L.) macrophages," Dev. Comp. Immunol. 17:319-330;
1993.
"Enhanced Healing of Decubitus Ulcers by Topical Application of Particulate
Glucan. Tulane University School of Medicine," Research Summary; 1984.
Federal Drug Administration, “Appendix A Food Additives,” Yeast
extract (Bakers) – FL/ADJ, GRAS, See Specs 184.1983. Washington DC.
Felippe J., Silva M., Maciel FM., et al: "Infection prevention in patients
with severe multiple trauma with the immunomodulator beta(I-3)glucan 1-3 polyglucose
(glucan)." Surg. Gynecol Obstet., 177:3833-3880; 1993.
Fernandez-Botran, Vetvicka V.: "Methods in Cellular Immunology,"
CRC Fitzpatrick, F.W., Dicario J.F., "Zymosan". Annals of the New
York Academy of Sciences; 118:233-262; 1964.
Fleet, G. H., et al: "Isolation and Composition of an Alkali-Soluble Glucan
from the Cell Walls of Saccharomyces Cerevisiae," Chemical Abstracts; 85:898192;
1976.
Fleet, G. H., et al: "Isolation and Composition of an Alkali-Soluble Glucan
from the Cell Walls of Saccharomyces Cerevisiae," Journal of General Microbiology;
94:180-192; 1976.
Fomusek L., Vetvicka V.: "Immune System Accessory Cells," CRC Press;
1992.
Franek, J., Malina, J., Kratka, K.: "Bacterial infection modulated by
glucan: a search for the host defense potentiation mechanisms," Folia Microbiol
(Praha) 37(2):146-152; 1992.
Gaffin, Int. J. Immunopharmac.: 14:173-183; 1992.
Giaimis, J., Lombard, Y., et al: "Both mannnose and beta-glucan receptors
are involved in phagocytosis of unopsonized, heat-killed Saccharomyces cerevisiae
by murine macrophages," J. Leukoc. Biol. 54:564-571; 1993.
Gilcrest, et al: J. Am. Acad. Dermatol., 5:411-422; 1982.
Gillet, et al: "Particulate beta-1-3 Glucan and Casual Prophylaids of
Mouse Malaria (Plasmodium berghei)." In advances in Exper. Med. And Biolog,
121A, Escobar and Friedman, Eds., Plenum Press, New York, Pgs. 307-313; 1980.
Glovsky, N. M., et al: "Effects of particulate beta-1,3 glucan on human,
rat, and guinea pig complement activity," J. Reticuloendothel Soc. 33:401413;
1983.
Goldman, R.: "Characteristics of the B-glucan Receptor of Murine Macrophages."
Exp.Cel. Res., 174:481-490; 1988.
Goldman, R: "Induction of a.beta.-1,3-D-Glucan Receptor in P388DI Cells
Treated with Retinoic Acid of 1,25-dihydroxyvitamin D(3)," Immunology;
63:319-324; 1988.
Goodson, William, Hohn, David, Hunt, Thomas K and Leung, Y.K: "Augmentation
of Some Aspects of Wound Healing by a Skin Respiratory Factor." Journal
of Surgical Research, 21:123-129; 1996.
Goto H., Yuasa K., Rylander R.: "(1-->3)-beta-D-glucan in indoor air,
its measurement and in vitro activity," Am J. Ind Med 25: 81-83.1994.
Green et al: "Preclinical Evaluation of V@R- 1513 27" An Orally Active
Chemotherapy Protector", Cancer Research, vol. 54,, issued Aug. 1, 1992
Hagiwara K., Kikuch M.: "Anti-virus agent." (Schlerotium glucanicum
et al). U.S. Patent 5320849. Issued June 14, 1994.
Hall, M. N., Linder, P.: "The Early Days of Yeast Genetics," Cold
Spring Harbor Laboratory Press, Cold Spring Harbor, New York. 1993.
Hamuro, et al: Immunomodulating Agents: Properties and Mechanisms, Chirgos,
eds., Marcel Dekker, Inc.; pp. 409-436. 1984.
Hara C., et al: "A Branched (l.fwdarw.3)-.beta.-D-Glucan From a Water
Extract of Dictyophora indusiata FISCIT" Carb. Res.; 145:237-246. 1986.
Harada, et a: "Agricultureal Biological, Growth and beta.-Glucan I OC3K
Production by a Mutant Of Alcaligenes faecalis var. myxogenes in Defined Medium"
Vol. 30, No. 8, pp. 764-769. 1966.
Harada, et al: "Production of a Firm, Resilient Gel-Forming Polysaccharide
by a Mutant of Alcaligenes faecalis var. myxogenes I OC3," Agr. Biol. Cherm;
Vol. 30, No. 2, pp 196-198. 1966.
Hartland R. P., Emerson, G. W., Sullivan, P. A.: "A secreted beta-glucanbranching
enzyme from Candia albicans," Pro K Soc Lond B Biol Sc@ 246 (I 316): 15
5-160. Biochem. Dept., University of Otago, Dunedin, New Zealand; 1991
Hassid, W. Z., Joslyn, M. A., McReady, R.M.: "The Molecullar Constitution
of an Insoluble Polysaccha-ride From Yeast Saccharomyces Cerevisae," Journal
of American Chemical Society, 63:295-298; 1941.
Hetland G, Sandven P; "Beta-1,3-Glucan reduces growth of Mycobacterium
tuberculosis in macrophage cultures," FEMS Immunol Med Microbiol 25;33(1):41-5.
Mar 2002.
Hofemeister: "The beta-glucanase gene from Bacillus amyloliquefaciens
shows extensive homology with that of Bacillus subtilis," Gene, 49:177187;
1986.
Holbrook, J. A. C., Parker, J. L.: "Immunization against Leigmania donovani:
glucan as an adjuvant with killed promastigotes," American Journal Tropical
Medicine Hygiene 30:762-768; 1981.
Holbrook, T. W., et al: "Glucan-Enhanced Immunogenicity of Killed Erythrocylic
Stages of Plasmodium Benghei," Infection and Immunity, 32:342; 1981
Honda, S., et al: "Activation of the alternative pathway of complement
by an antitumor (I ---- 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes
IFO 13140, and its lower molecular weight and carboxymethylated derivatives,"
Immunopharmacology 11:29-37; 1986.
Hunter KW, Gault RA, Berner MD, "Preparation of microparticulate B-glucan
from Saccharomyces cerevisiae for use in immune potentiation." Letters
in Applied Microbiology," Vol 35 Issue 4, 267-271, October 2002.
Inai, et al: "Activation of the Alternative Complement Pathway By Water-Insouble
Glucans of Streptococcuss mutans: the Relation Between Their Chemical Structures
and Activating Potencies." Journal of Immunology, 117:1256-1260; 1976.
Inamuzu, T., Chang, M. P., Makinodan, T.: "Influence of Age on the Production
and Regulation of Interleukin- I in Mice," Immunology, Vol. 55, p.44; 1985.
Ishibashi K, Miura NN, et al, "Relationship between the physical properties
of Candida albicans cell well beta-glucan and activation of leukocytes in vitro,"
Int Immunopharmacol 2(8):1109-22. Jul 2002.
Jacques, et al: "Immunomodulator Polysacharides," Current Concepts
in Human Immunology and Cancer Immunomodulation, Seffon et al., Eds. Elsevier
Biomedical Press BV, Pgs. 429-438; 1982.
Jamas, S., Easson, D., Ostroff, G. R., Davidson, D.: "Method for producing
soluble glucans," U.S. Patent 5633369. Issued May 27, 1997.
Jamas, S., Easson, D., Ostroff, G. R.: "Glucan Preparation," U.S.
Patent 5622939. Issued April 22, 1997.
Jamas, S., Easson, D., Ostroff, G. R.: "Glucan drug delivery system and
adjuvant," U. S. Patent 5 607677. Issued March 4, 1997.
Jamas, S., Easson, D., Ostroff, G. R.: "Use of aqueous soluble glucan
preparations to stimulate platelet production." U.S. Patent 5532223. Issued
July 2, 1996.
Jamas, S., Easson, D., Ostroff, G. R.: "Use of neutral soluble glucan
preparations to stimulate platelet production." U.S. Patent 5488040. Issued
January 30, 1996.
Jamas, S., Easson, D., Ostroff, G. R.: "Method for producing neutral glucans
for pharmaceutical applications," U.S. Patent 5322841. Issued June 21,
1994.
Jamas, et al: "A Novel Class of Macrophage-Activating Immunomodulators,"
ACS Series, Polymeric Drugs and Delivery Systems; Chapter 5, pp. 44-51; 1991.
Jamas, S., et al: Biotech. and Bioeng, 1986; 28: 769-784; 1986.
Jamas S., et al: "In: Industrial Polysaccharides: Genic Engineering Structure/Property
Relations and Appl.," Elserier Science Publ. B.V., Amsterdam N.C., Pgs.
05-09.
Jamas, S., Chen, Y-CJ, Von der Osten, C.H., et al: "Spectral analysis
of glucan produced by wud-type and mutant Saccharomyces cerevesiae." Carbohydrate
Polym., 13:207-219; 1990.
Janusz, M. J., Austen, K. F., Czop, J. K: "Isolation of a Yeast Heptaglucoside
that Inhibits Monocyte Phagocytosis of Zymosan Particles." The Journal
of Immunology; 142:959-965; 1989. Dept. of Medicine Harvard Medical School,
Boston, MA.
Janusz, M. J., Austen, K. F., Czop J. K.: "Phagocytosis of Heat-killed
Blastophores of Candida Albicans by Human Monocyte B-glucan Receptors."
Immunology, 65:181-185; 1988.
Janusz, M. J., Austen, K. F., Czop J. K.: "Lysosomal enzyme release from
human monocytes by particulate activators is mediated by beta-glucan inhabitable
receptors," J. Immunol 138: 3897-3901; 1987.
Janusz, M. J., et al: "Isolation of Soluble Yeast Beta-Glucan that Inhibit
Human Monocyte Phagocytosis Mediated by Beta-Glucan Receptors," L. Immunol.,
137:3270-3276; 1986.
Jiang, B., Sheraton, J., et al: "CVH41 encodes a novel endoplasmic reticulum
membrane N-glycoprotein involved in beta 1,6-glucan assembly," J. Bacteriol
178:1162-1171; 1996.
Jones, E. W., Broach, J. R., and Pringle, J. R.: "The Molecular and Cellular
Biology of the Yeast Saccharomyces Cerevisiae," Gene Expression, Cold Springs
Harbor Laboratory Press, Cold Spring Harbor, New York; 1992.
Jorgensen, J. B., Robertsen, B.: "Yeast beta-glucan stimulates respiratory
burst activity of Atlantic salmon (Salmo salar L.) macrophages," Dev. Comp.
Immunol. 19:43-57; 1995.
Jorgensen, J. B.: "Quantification of high molecular weight (1-3)(1-4)-beta-D-glucan
using calcofluor complex formation and flow injection analysis."
Kadish, J. L., Choi, C. C., Czop, J. K.: "Phagocytosis of unopsonized
zymosan particles by trypsin-sensitive and beta-glucan-inhibitable receptors
on bone maffow-derived murine macrophages," Immunol Res 5: 129-138; 1986.
Kallin, E., et al: "New Derivatization and Separation Procedures for Reducing
Oligosaccharides," Glycoconjugate J., Pgs. 311-319; 1984.
Kan, V. L., Bennett, J. E.: "Beta 1,4-oligoglucosides inhibit the binding
of Aspergillus fimfigatus conidia to human monocytes," Journal Infectious
Diseases 163:1154-1156; 1991.
Kaplan J.: "Acceleration of Wound Healing by a Live Yeast Cell Derivative."
Archives and Surgery, 119:1005-1008; 1984.
Kapteyn, J. C., Montijn, R. C., et al: "Retention of Saccharomyces cerevisiae
cell wall proteins through a phosphodiester-finked beta-1,3/beta-1,6-glucan
heteropolymer," Glycobiology 6:337-345; 1996. Institute of Molecular Cell
Biology, University of Amsterdam, The Netherlands.
Kapteyn, J. C., Montijn, R. C., et al: "Covalent association of beta-1,3-glucan
with beta-1,6-glucosylated mannoproteins in cell wars of Candida albicans,"
J. Bacteriol 177:3788-3792; 1995.
Kapteyn, J. C., Montijn, R. C., et al: "Glucosylation of cell wall proteins
in regenerating spheroplasts of Candida albicans," FEMS Microbiol Letter
128:271-277; 1995.
Kapteyn, J. C., Montijn, R. C., et al: "Identification of beta-1,6-glucosylated
cell wall proteins in yeast and hyphal forms of Candida albicans," Euro.
J. Cell. Biol. 65:402-407; 1994.
Kasahara, S., Ben Inoue, S., Mio, T., Yamada, T., Nakajima, t., Ichishima,
E., Funiichi, Y., Yamada, H.: "Involvement of cell wall beta-(1-3)glucan
in the action of HM- I killer toxin," FEBS. Lett. 348(1):27-32; 1994.
Kasai, S., Fujimoto, S., Nitta, K., Baba, H., Kunimoto, T.: "Antitumor
activity of polymorphonuclear leukcytes activated by a B-1,3-D-glucan."
J. Pharmacobiodyn, 14:519-525; Medline.
Kashkina, M. A., Freidlin, I. S.: "Macrophage activation by polysaccharides
from yeast-like fimgi," Bull. Eurp. Biol. Med. 89(4):439-441; 1980.
Kay J., Czop J.K.: "Enhancement of human monocyte beta-glucan receptors
by glucocorticoids," Immunology 81:96-102; 1994.
Kapteyn J.C., Montijn R.C., et al; “Retention of Saccharomyces cerevisiae
cell wall proteins through a phosphodiester-linked beta-1,3/beta-1,6-glucan
heteropolymer,” Glycobiology 6: 337-345. 1996.* Institute of Molecular
Cell Biology, U of Amsterdam, The Netherlands.
Kiistala, et al: J. Investigative Dermatol., 48:466-477; 1967.
Kimura, et al: "In Vitro Activation of Human Adherent Cefls by a Glucan,
Schizophyllan." J. Reticuloendothel, Soc. 34:1-11; 1983.
Kohl, et al.: "Inhibition of Human Monocyte-Macrophage and Lymphocyte
Cytotoxicity to Herpes-simplex Cells by Glucan" J. Immunol. Methods, 29:361-368;
1979.
Kokoshis, P. L., Williams, D. L., Cook, J. A., Di Luzio, N. R.: "Increased
resistance to Staphylococcus aureus infection and enhancement in serum lysozyme
activity by glucan." Science 199:1340-1342; 1978.
Kollar R, Kapteyn J, et al; “Architecture of the yeast cell wall. Beta
1,6 glucan interconnects manoprotein, beta 1,3 glucan and chitin,” J Biol
Chem, 272:28,17762-75. Jul 1997.
Konopski, Z., Seljelid, R., Eskeland, T.: "Interferon-gamma inhibits endocytosis
of soluble animated beta-1,3-D-glucan and neutral red in mouse peritoneal macrophages,"
J. Interferon Cytokine Res. 15(7):597603. Department of Experimental Pathology
and Anatomy, University of Tromso, Norway.
Konopski, Z., Seljelid, R., Eskeland, T.: "IFN-gamma inhibits internalization
of soluble aminated beta-1-3-D-glucan by macrophages and thereby down-regulates
the glucan induced release of TNF-alpha and IL-1 beta," Scand. J. Immunol.
40:57-63; 1994.
Konopski, Z., Seljelid, R., Eskeland, T.: "A novel immunomodulator soluble
aminated beta-1,3-D-glucan: binding characteristics to mouse peritoneal macrophages,"
Biochem. Biophys. Acta. 1221(l):61-65; 1994.
Konopski, Z., Seljelid, R., Eskeland, T.: "Cytokines and PGE2 mondulate
the phagocytic function of the beta-glucan receptor in macrophages," Scand.
J. Immunol. 37:587-592; 1993.
Konopski, Z., et al: "Phagocytosis of.beta.-1,3-D-Glucan-Derivatized Microbeads
by Mouse Peritoneal Macrophages Involves Three Different Receptors," Scand.
J. Immunol., 33:297-306; 1991.
Kopecka M.: "Electron microscopic study of purified polysaccharide components
glucans and mannan of the cell walls in the yeast Saccharomyces cerevisiae,"
J. Basic Microbiol. 25:161-174; 1985.
Kopecka, M., et al: The Journal of Cell. Biology, 62:66-76; 1974.
Lahnborg, G., Hedstrom, K. G., Nord, C. E.: "The Effect of Glucan - A
Host Resistance Activator and Ampicillin on Experimental Intraabdominal Sepsis,"
Journal of Reticuloendomenal Society. 32:347-355; 1982.
Lahnborg, et al: "Glucan-Induced Enhancement of Host Resistance in Experimental
Intraabdominal Sepis." Eur. Surg. Res., 401-408; 1982.
Larm, O., Seljelid, R.: "Water-soluble aminated beta-1,3-D-glucan and
composition containing same," U.S. Patent 470747 1; Issued Nov 17, 1987.
Leibovich, S. I., et al: "Promotion of Wound Repair in Mice by Application
of Glucan." J. Reticuloendothel, Soc. 27:1-11; 1980.
Lejeune, F. J., Vercammen-Granfjean, A., Mendes da Costa, P., Bron, D., Defleur,
V.: "Supressor cell induction and reticuloendothelial cell activation produced
in the mouse by beta(1-3)glucan," Adv. Exp. Med. Biol. 121(A):235-244;
1979.
Lotzova and Gutterman: "Effect of Glucan on Natural Killer (NK) Cells:
Further Comparison Between NK Cell and Bone Marrow Effector Cell Activities."
J. Immunol., 123:607-611; 1979.
Mahauthaman, R., Howell, C. J., Spur, B. W., Youlten, L. J., Clark, T. J.,
Lessof, M. H. and Lee, T. H.: "The generation and cellular distribution
of leukotriene C4 in human eosinophils stimulated by unopsonized zymosan and
glucan particles," J. Allergy Clin. Immunol. 81:696; 1988.
Manners, D. J., Masson, A. J., and Patterson, J. C.: "Heterogeneity of
Glucan Preparations from The Walls of Various Yeasts." J. of Gen. Micro.,
41:1417; 1974.
Manners, D.J., et al: "The Structure of beta-(l-3)-D-Glucan from Yeast
Cell Walls," Biochem, I., 135:19-30; 1973.
Mansell, P. W. A., Rowden, G., Hammer, C.: "Clinical experiences with
the use of glucan." Chirigos MA, ed.; Immune Modulation and Control of
Neoplasia by Adjuvant Therapy. Raven Press, New York, 255-280; 1978.
Mansell, P. W. A., Ichinose, H., Reed, R. J., Krements, E. T., McNamee, R.
B., Di Luzio, N. R.: "Macrophage-medicated Destruction of Human Malignant
Cells in Vivo." Journal of National Cancer Institute, 54:571-580; 1975.
Mansell, P. W. A. and DiLuzio N. R.: "Macrophage in Neoplasia Fink,"
Ed. Academic Press, New York, Pgs. 227-243; 1976.
Mansell, P. W. A., et al: "Activation of the Alternative Complement Pathway
by Water-Insouble Glucans of Streptococcus mutans: the Relation Between Their
Chemical Structures and Activating Potencies". Macrophage-Mediated Destruction
of Human Malignant Cells In Vitro; Inai et al, J. Immunol. 1256-1260; 1976.
Mansell, P. W. A., Ichinose, H., Reed, R. J., Krements, E. T., McNamee, R.
B., Di Luzio, N. R.: "Macrophage-mediated Destruction of Human Malignant
Cells in Vitro." Journal of National Cancer Institute, 54:571-580; 1975.
Marchetti, M., Pisani, S., Pietropaolo, V., Seganti, L., Nicoletti, R., Degener,
A., Orsi, N.: "Antiviral effect of a polysaccharide ftom Sclerotium glucanicum
towards herpes simplexx virus type I infection," Planta. Med. 62(4):303-307;
1996.
Marrow, S. H., Di Luzio, N. R.: "The fate of foreign red cells in mice
with altered reticuloendothelial function." Proc. Soc. Exp. Biol. Med.
119:647652; 1965.
Mamyama, K., Yamamoto, K., Nagura, S.: "Method for purifying polysaccharides,"
U.S. Patent 5602241, Issued February 11, 1997.
Mashiba, et al: "In Vitro Activation of Human Adherent Cells by a Glucan
Schlzophillan." Japan J. Exp. Med. 53:195-198; 1983.
McCleary: "Soluble, dye-labeled polysaccharides for the assay of endohyrolases,"
Methods Enzymol, 160:74-86; 1988.
Meira, D. A., et al: "The Use of Glucan as immunostimulant in the Treatment
of Paracoccidioidomycosis," Am. J. Trop. Med. Hyg. 55(5), 496-503; 1996.
Dept. of Trop. Dis., Dept. of Microbio., State Univ. of Sao Paulo, Brazil.
Mitsutake, K., et al: "Enolase Antigen, Mannan Antigen, Cand-Tec Antigen,
and (-Glucan in Patients with Candidemia," J. of Clin. Microb., Pgs l9l8-1921,
1137; 1996. Sec. Dept. of Int. Med., Nagasaki Univ. School of Medicine, Nagasaki,
Japan.
Nfiura, N. N., Ohno, N., Adachi, Y., Yadomae, T.: "Characterization of
sodium hypochlorite degradation of beta-glucan in relation to its metabolism
in vivo," Chem. Pharm. Bulletin (Tokyo) 44:2137-2141; 1996.
Miyazaki, T., et al: "Structural Examination of Antitumour, WaterSoluble
Glucans from Grifora umbrellata by Use of Four Types of Glucanase," Carbohydrate
Research; 65:235-243; 1978.
Morikawa, K., Takeda, M., Yamazaki, M., and Mizuno, D.: "Induction of
tumoricidal activity of polymorphonuclear leukocytes by a linear B-1,3-Dglucan
and other immunomodulators in murine cells." Cancer Res. 45:1496-1501;
(Medline)
Montijn, R. C. et al: "Glucomannoproteins in the cell wall of Saccharomyces
cerevisiae contain a novel type of carbohydrate side chain," J. Biol. Chem.,
269(30):19338-19342: Inst. of Molecular C. Biol. U. of Amsterdam, The Netherlands.
1994.
Mortimer, M., Contopoulou, C. R., King, J.S.: "Genetic and physical maps
of Saccharomyces Cerevisiae," Edition II. Yeast 8:817-902; 1992.
Muller, A., Rice, P. J., Ensley, H. E., et al: "Receptor binding and internalization
of a water-soluble (1-->3)-beta-D-glucan biologic response modifier in two
monocyte/macrophage cell lines," J. Immunol 156:34183425; 1996.
Murphy: "The DNA sequence of the gene and genetic control sites for the
execreation B. subtilis enzyme beta-glucanese," Nucleic Acids Res., 12:5355-5367;
1984.
Muto, S., Vetvicka, V., Ross, G. D.: "CP3 expressed by cytotoxic T cells
and NK cells is upregulated in a manner similar to neutrophils following stimulation
with various activating agents," J Clin Immunol 13:175-184; 1993.
Nemoto, J., Ohno, N., et al: "Analysis of cytoldne in mBNAs induced by
the administration of a highly branched (1-3)-B-D-glucan." OL-2. Biol.
Pharm. Bull. 17:948-54; 1994.
Nicolosi, R et al. Plasma lipid changes after supplementation with B-glucan
fiber from yeast. Amer J Clin Nutr 70, 208-12 ,1999.
Niki, L., Allbright, L.: "Composition and method to enhance the efficacy
of a fish vacine and to stimulate the immune system of fish." (A method
to stimulate the immune system by a beta(1-3)glucan having a beta(1-3) glucan-1,3-linked
main chain with beta(1-3)glucan-1,6-linked single glucose side chains,"
U.S. Patent 5189028. Issued February 23, 1993.
Niskanen, E. O., Burgaleta, C., Cline, M. J., Goide, D. W.: "Effect of
glucan, a macrophage activator, on murine hemopoietic cell proliferation in
diffusion chambers in mice," Cancer Res. 38:1406-1409; 1978.
Norton, M. D., JA [Prof. of Surg., Chief of Endocrine and Oncologic Surgery]:
"Editorial: Annals of Surgery," Washington University School of Medicine;
1994.
Nuyen and Stadtsbaeder: "Comparative Biological and Antitoxoplasmic Effects
of Polysaccharides, In Vitro" in Advances in Exper. Med. and Biology, Vol.
121A Escobar and Friedman, Eds. Plenum Press, New York, Pgs. 255-266; 1980.
Ohno, N., Terui, T., Chiba, N., Kurachi, K., Adachi, Y., Yadomae, T.: "Resistance
of highly branched (1-3)-beta-D-glucans to formolysis," Chem. Pharm. Bulletin
(Tokyo) 43:1057-1060; 1995.
Olson, E. J., Standing ,J. E., et al: "Fungal beta-glucan interacts with
vitronectin and stimulates tumor necrosis factor alpha release from macrophages,"
Infect. Immun. 64:3548-3554; 1996.
Onderdonk, A. B., et al: "Anti-Infective Effect of Poly beta. 1-6 Glucotrisyl
beta 1-3-Glucopyranose Glucan In Vivo," Infec. Immun., 60:1642-1647; 1992.
Dept. of Pathology, Channing Lab, Brigham and Women's Hospital Boston, MA.
Ostroff, G. R.: "Inhibition of infection-stimulated oral tissue destruction
by beta (I-3)glucan," U.S. Patent 5622940. Issued April 22, 1997.
Ostroff, et al: "Manipulation of Yeast Glucan Structure: Molecular Weight,
Branch Frequency and Branch Length". The Fermentor, 9(12) L51, American
Cancer Society; Abstract No. 19.; Aug 1989.
Patchen M.L.: [V Chrm, Dept. of Surg., University of Washington], et al "Mast
Cell Growth Factor (c-kit Ligand) in Combination with Granulocyte-Macrophage
Colony@- Stimulating Factor and Interleukin-3: in vivo Hemopoietic effects in
Irradiated Ice compared to in vivo effects," Biotherapy, Vol. 7. Pgs. 13-26;
1994.
Patchen, M.L., et al: "Effects of Combined Administration of Interleukin-6
and Granulocyte Colony Stimulating Factor on Recovery from Radiation Induced
Hemopoietic Aplasia," Experimental Hematology, Vol. 21, Pgs. 338-344. 1993.
Patchen, M. L.: D'Alesandro M. M., Brook, I., Blakely, W. F., McVittie, T.
J.: "Glucan: Mechanisms Involved in Its Radioprotective Effect." J.
Leuc. Biol., 42:95-105; 1987.
Patchen, M. L., MacVittie, T. J.: "Comparative effects of soluble and
particulate glucans on survival in irradiated mice," J. Biol. Response
Mod. 5(l):45-60. Experimental Hematology Dept, Armed Forces Radiobiology Research
Inst, Bethesda, MD, 1986.
Patchen, M. L., McVittie, T. J.: "Stimulated Hemopeiesis and Enhanced
Survival Following Glucan Treatment in Sublethally and Lethally Irradiated Mice."
Int. J. Immunopharmac; 7: 923-932. 1985.
Patchen, M. L., et al: J. Biol. Res. Mod., 3:627-633; 1984.
Patchen, M. L., McVittie, T.J.: "Temporal Response of Murine Pluripotent
Stem Cells and Myeloid and Erythroid Progenitor Cells to Low-dose Glucan Treatment."
Acta. Hemat., 70:281-288; 1983. Experimental Hematology Dept., Armed Forces
Radiobiology Research Inst. Bethesda, MA.
Patchen, M. L.: "Survey of Immunological Research," 2:237-242; 1983.
Patchen, M. L., Lotzova, E.: "Modulation of Murine Hemopoiesis by Glucan,"
Exp. Hermatol 8:409-422; 1980.
Patchen M.L., Vaudrain T, Correira H, Martin T, Reese D, “In vitro and
in vivo hematopoietic activities of Betafectin PGG-glucan.”, Exp Hematol,
26(13):1247-54. Dec 1998.
Patent Abstracts of Japan: "Production of beta-1,3-glucan," 1989,
Vol. 13, No. 224, (C-599) {3572) & Japanese Patent Application No. 137297;
1989.
Patent Abstracts of Japan: "Production of beta-1,3-glucan by cell of genus
Euglena," 1988, Vol. 12, No. 299, (C-520) (3141) & Japanese Patent
Application No. 6371192, 1988.
Paulik, S., Svrcek, S., et al: "The effect of fungal and yeast glucan
and levamisole on the level of the cellular immune response in vivo and leukocyte
phagocytic activity in mice," Vet Med (Praha) 37: 675-685. 1992.
Petre, et al: "Purification and properties of an endo-.beta.-1,4-glucanase
from Clostridium thermocelluni," (abst.) 7-Enzymes, (1981) 95:1458799,
Biochemie; 63:629-639; 1981.
Popisil, et al: "Glucan Induced Hemopoietic Recovery in GammaIrradiated
Mice." Experientia, 38:1232-1234; 1982.
Poutsiaka, D. D., et al: "Cross-Linking of the beta-glucan receptor on
human monocytes results in interleukin-1 receptor antagonist but not interleukin-1
production," Blood 82:3695-3700; 1993. Dept. of Med., New England Med.
Ctr., Boston, MA.
Pretus, H. A., et al.: "Isolation, Physicochemical Characterization and
Preclinical Efficiency Evaluation of Soluble Scleroglucan," The Journal
of Pharmacology and Experimental Therapeutics, 500-510; 1991.
Price, G. B., Makinodan, T.: "Immunologic Deficiencies in Senescence."
The Journal of Immunology, 108:403-312; 1972.
Proctor, et al.: "Development of a Bioassay for Anti-Tumor Activity of
the Peticuloendoethelial Stimulant Class: Reproductibility of the Bioassay."
J. Immunophamacol., 3:385-395; 1982.
Proctor, J. W., Stiteler, R. D., Yamamura, Y., Mansell, P. W., Winters, R.:
"Effect of glucan and other adjuvants on the clearance of radiolabeled
tumor cers from mouse lungs", Cancer Treat. Rep. A2(11):1873-1880; (1978).
Proctor and Yamamura: "Letters to the Editor: Effectiveness of Glucan
in the Treatment of Human Neoplasia.." J. Nat'l Cancer Inst., 61:1179-1180;
1978.
Raa, J., Roerstad, G., Engstad, R., Robertsen, B.: "The Use of linmunostimulants
to Increase Resistance of Aquatic Organisms to Microbial Infection". J.
Dermatol. Surg. Oncol., 15:1199-1202; 1989.
"Radioprotective Effect of Oral Administration of Beta(1-3)glucan"
Research Report, Armed Forces Radiobiology Research Institute, Bethesda, MA
1989.
Rasmussen, L. T, Konopski, Z., Oian, P., Seljelid, R.: "Killing of Escherichia
coli by mononuclear phagocytes and neutrophils stimulated in vitro with beta-1,3-D-polyglucose
derivatives," Microbiol. Inimunol. 36(11):1173-1188; 1992. Inst. of Med.
Bio. University of Tromso, Norway.
Rasmussen, L. T., Seljelid, R.: "Novel Immunomodulators With Pronounced
In Vitro Effects Caused by Stimulation of Cytokine Release," Journal of
Cellular Biochemistry; 46:60-68; 1991. Inst. of Med. Bio., University of Tromso,
Norway.
Rasmussen, L. T. Seljefid R: "Dynamics of blood components and peritoneal
fluid during treatment of murine E. coli sep sis with beta-1,3-D-polyglucose
derivatives. I. Cells." Scand. J. Immunol. 32(4):321-331; 1990.
Rasmussen, L. T., Seljefid, R.: "Dynamics of blood components and peritoneal
fluid during treatment of murine E. coli sepsis with beta-1,3-D-polyglucose
derivatives. II. Interleukin 1, tumour necrosis factor, prostaglandin E2 and
leukotriene B4," Scand J Immunol 32(4):333-340. 1990.
Rasmussen, L. T., Seljelid, R.: "The modulatory effect of lipoproteins
on the release of interleukin I by human peritoneal macrophages stimulated with
beta-1,3-D-polyglucose derivatives." 1989.
Rasmussen, L. T., Seljelid, R.: "Production of prostaglandin E2 and interleukin
I by mouse peritoneal macrophages stimulated with beta-1,3-D-glucan", 1987.
Rasmussen, L.T., Fandrem, Seljelid, R.: "Dynamics of Blood Components
and Peritoneal Fluid During Treatment of Murine E. Coli Sepis with beta-1,3-D-polyglucose
Derivatives," Scand. J. 63:73-80 Immunol; 1985.
Ray P. M.: "Cooperative action of beta-glucan synthetase......" Biochem.
Biophys. Acta. 629:431-444; 1980.
Reynolds, J. A., et al: "Glucan-Induced Enhancement of Host Resistance
to Selected Infectious Diseases," Infection and Immunity, 30:51; 1980.
Riggi and DiLuzio N.R.: "Hepatic Function during Reticuloendothelial Hyperfunction
and Hyperplasia." (1962) 193:1292-1294; 1962.
Riggi and DiLuzio, N.R: Am. J. Physiol., 200:297-300; 1961.
Rios-Hemandez, M., Dos-Santos, N. J., Silvia-Cardosa, Belle-Garciga, J. L.,
Peddrosa, M.: "Immunopharamacological studies of beta(1-3)glucan",
Arch. Med. Res. 25 (2):179-180; 1994.
Robertsen, B., Engstad, R. E., Jorgensen, J.B.: "Beta(I-3)glucan-glucans
as Immunostimulants in Fish". Modulators of Fish Immune Responses, Vol.
1; 1994.
Roemer, T., et al: "Characterization of the yeast (1-->6)-beta-glucan
biosynthetic components, SKN1 AND KRE6 genetic interactions between the PKC1
pathway and the extracellular matrix assembly," J. Cell. Bio. 127(2):567-579;
1994.
Roemer, T., Delaney, S., Bussey, H: "SKN I and KRE6 define a pair of funcitonal
homologs encoding putative membrane proteins involved in beta-glucan synthesis,"
Mol. Cell. Biol. 13(7):4039-4048. Bio. Dept. McGill Univ., Montreal Quebec,
Canada, 1993.
Roemer, T., Bussey, H.: "Yeast beta-glucan synthesis: KRE6 encodes a predicted
type H membrane protein required for glucan synthesis in vitro and for glucan
synthase activity in vitro," Proc. Natl. Academy Science USA, 88(24):11295-11299;
1991.
Roos, D., Van Schaik, M.L.F., de Boer, M., Daha M.R.: "Interaction between
neutrophils and zymosan particles: the role of opsonin and divalent cations;"
J. Immunol. 126:433; 1981.
Ross G.D., Vetvicka V.: "CR3: A phagocyte and NK cell membrane receptor
with multiple ligand specificities and functions," Clin. Exp. Immunol.
92:181-184; 1993.
Ross, G. D., Cain, J.A., Myones B.L. et al: "Specificity of membrane complement
receptor type three (CR3) for beta-glucans," Complement 4:61-74; 1987.
Ross, P., Mayer, R., Benziman, M.: "Cellulose biosynthesis and function
in bacteria," Microbiol. Rev. 55:35-58; 1991.
Sakata, T., von Englehardt, W.: Vol. 45, No. 174, Pgs. 58835-58836. 1980.
Sakuria: Int. J. Immunopharmac., 14:821-830; 1992.
Sakuria: Int. J. Immunopharmac., 12:675-684; 1990.
Sandula, J., Machova, E., Hribalova V.: "Mitogenic activity of particulate
yeast beta-(I-->3)-D-glucan and its water soluble derivatives," Int.
J. Biol. Macromol. 17:323-326. 1995.
Sandula, et al: Folia Microbiological; 21(3), Page 188; 1976.
Sanjuan, R., Zueco, J., Stock, R., Font de Mora, J., Sentandreu, R.: "Identification
of glucan-mannoprotein complexes in the cell wall of Candida albicans using
a monoclonal antibody that reacts with a (1,6)beta-glucan epitope," Microbiology,
141(Pt 7):1545-1551; Dept. de Microbio. Faculitat de Farmacia, U. de Valencia,
Burjassot, Spain; 1995.
Sarko, et al: "Multiple-Helical Glucans" Biochem. Soc. Trans., 11:139142;
1983.
Sasaki, et al: "Antitumor Activity of Tetrahydro-2-furnal-antetrahydro-2-pyranyl-Glucans
Obtained by Chemical Modification of (1,3)-beta-D-glucan from Alcaligenes faecalis
var. myxogenes IFO 13140 and its Lower Molecular Weight Glucans" Cancer
Treat Rep. (1983) Rep. 67:275-280; 1983.
Sasaki, et al: "Effect of Serum from Mice Treated with Antitumor Polysaccharide
on Expression of Cytotoxicity by Mouse Peritoneal Macrophages". J. Pharm
Dyn.; 5:1012-1216; 1982.
Sasaki, et al: "Dependence on Chain Length of Antitumor Activity of (1,3)-beta-D-Glucan
from Alcaligenes faecalis var. myxogenes IF013140, and its Acid-degraded Products".
Cancer Research, 38:379-383, 1978.
Satoh, et al: "Elevation of Colony Stimulating Factors in Mouse Serum
After Injection of PSK, an Antitumor Polysaccharide." J. Pharm. Dyn.; 5:818-828.
1982.
Schimanski, D.: "Cosmetic agent containing natural yeast cell contents,"
U.S. Patent 4540571; Issued Sep 10, 1985.
Schultz, et al: "Immune Modulation and Control of Neoplasia by Adjuvant
Therapy," Chirigos, ed., Raven Press, New York, Pgs. 241-248; 1978.
Schultz, et al: "Association of Macrophage Activation with Anti-tumor
Activity by Synthetic and Biologic Agents". Cancer Res., 37:3338-3343;
1977.
Schwarz, et al: "Isolation of a Clostridium thermocellum gene encoding
a thermostable beta-1,3-glucanase (laminarinase)," Chemical Abstracts,
(1988); 108:217067k, Biotechnology letters; 10(4):225-230. 1988.
Schwarz, et al: "Association of Macrophage Activation with Anti-tumor
Activity by Synthetic and Biologic Agents." Cancer Res., 37:3338-3343,
1977.
Seljelid, R., Busund, L.T.: "The biology of macrophages: U. Inflammation
and tumors," Euro. J. Haematol 5 2(l):1-12. 1994. Dept. of Exp. Pathoth.
Inst. of Med. Diol. Univ. of Tromso, Norway.
Seljelid, R., Eskeland, T.: "The biology of macrophages: I. General principles
and properties," Euro. J. Haematol. 51(5):267-275. 1993.
Seljelid, R., et al: "Evidence that tumor necrosis induced by aminated
beta 1-3D polyglucose is mediated by a concerted action of local and systemic
cytokines," Scand. J. Immuno. 30(6):687-694; 1989.
Seljelid, R: "Tumour regression after treatment with aminated beta 1-3D
polyglucose is initiated by circulatory failure," Scand. J. Immunol. 29(2):181-192;
1989.
Seljelid, R.: "Macrophage Activation" Scand. J. Rheumatology; Suppl.
76:67-72; 1988.
Seljelid, R.: "The rediscovery of the macrophage," APMIS Suppl 2:215223;
1988.
Seljelid, R., et al: "The protective effect of beta 1-3D-glucan-derivatized,"
25(l):55-60. 1987.
Seljelid, R.: "A water-soluble aminated beta 1-3D-glucan derivative causes
regression of solid tumors in mice," Biosci. Rep. 6(9):845-851. 1986.
Seljelid, R., et al: "In vivo activation of mouse macrophages with beta-1,3-D-glucan-derivatized
plastic beads," Scand. J. Immunol. 21(6):601-605. 1985.
Seljelid, R., et al: "A Soluble beta.- 1,3-Glucan Derivative Potentiates
the Cytostatic and Cytolytic Capacity of Mouse Peritoneal Macrophages In Vitro."
Immunopharmacol 7:69-73; 1984.
Seljelid, R., et al: Exper. Cell. Res., 131:121-129; 1981.
Seffon, et al: "Immunomodulators Polysaccharides," Jacques, in Current
Concepts in Human Immunology and Cancer Immunomodulation, Eds., Elesevier Biomedical
Press BV.; Pgs. 429-438; 1982.
Shandula, I., Kogan, G., Masler, L.: "Structure and various characteristics
of yeast beta-D-glucans," Vopr Med Khim 36:39-42; 1990.
Sherwood, E. R., et al: "Soluble Glucan and Lymphokine-activated Killer
(LAK) Cells in the Therapy of Experimental Hepatic Metastases," Chemical
Abstracts; 108:1797526. 1988.
Sherwood, E. R., et al: "Enhancement of Interleukin-I and Interleucan-2
Production by Soluble Glucan," International Journal of Immunopharmacology.,
9:(3):261-267; 1987.
Shibata, Y.: "Enzymatic hydrolysis of glucans containing beta-1,3 and
beta-1,6-linkages. 3. Gibberefla beta-1,6-glucan, 6-glucanohydrolase operative
in the selective hydrolysis of beta-1,3-glucosidic linkages in Eisemia laminaran,"
J. Biochem. (Tokyo) 75:85-92; 1974.
Shiota, M., Nakajima, T., Satoh, A., Shida, M., Matsuda, K.: "Comparison
of beta-glucan structures in a cell wall mutant of Saccharomyces cerevisiae
and the wild type," J. Biochem. (Tokyo) 98:1301-1307; 1985.
Sietsma, J. H., et al: Journal of General Microbiology; 125:209-212. 1981.
Sima, P., Vetvicka, V.: "Evolution of Immune Reactions," Critical
Reviews in Immunology, 13:83-114; 1993.
Sima, P., Vetvicka, V.: "Evolution of Immune Reactions," CRC Press;
1990.
Smedsrod, B., Seljelid, R.: "Fate of intravenously injected aminated beta
(1 ---- 3) polyglucose derivatized with 1251-tyraminyl ceflobiose," Immunophar.
21(3):149-158; 1991.
Song, DuLuzio, N. R.: Lysosomes in Biology and Pathology, Dingle et al, eds.
North Holland Press Amsterdam; 6:533-547; 1979.
Spiros, J.: "Method for immune system activation by administration of
beta(1-3) glucan which is produced by Saccharomyces Cerevisiae strain R4,"
U.S. Patent 5504079; 1996.
Spiros,J.: "Use of neutral soluble glucan preparations to stimulate platelet
production," U.S. Patent 5488040; 1996.
Spiros, J., Rha, C., Sinskey, A. J.: "Glucan compositions and process
for preparation thereof" U.S. Patent 4810646; Issued Mar 7, 1989.
Stashenko, et al: "Reduction of Infection- Stimulated Periapical Bone
Resorption by the Biological Response Modifier PGG Glucan," J. Dent. Res.;
74(l):323-330; 1995. Dept. of Cytokine Biology, Forsyth Dental Ctr., Boston,
MA.
Stashenko, et al.: "Inhibition of Periapical Bone Resorption by a Biological
Response Modifier", J. Dent. Res., Res.73, No. 146; 1994.
Steadman, R., Petersen, M. M., et al: "Differential augmentation by recombinant
human tumor necrosis factor-alpha of neutrophil responses to particulate zymosan
and glucan," J. Immunol 144:2712-2718; 1990.
Stewart, et al: "Preliminary Observations on the Effect of Glucan in Combination
with Radiation and Chemotherapy in Four Murine Tumors," Cancer Treat. Prep.
62:1867-72; 1978.
Suga, et al: "Antitumor Activity of Lentinan in Murine Syngeneic and Autochthonons
Hosts and its Supressive Effect on 3-Methylcholanthrene-Induced Carcmogenesis."
Cancer Res., 44:5152-5157; 1984.
Surarit, R., Gopal, P. K., Shepherd M. G.: "Evidence for a glycosidic
linkage between chitin and glucan in the cell wall of Candida albicans,"
J. Gen Mcrobiol 134:1723-1730. 1988.
Suzuki, T., Ohno, N., Adachi, Y., Yadomae, T.: "Serum components induce
beta-D-glucan-inhibitable uptake of zymosan particles by murine peritoneal macrophages,"
Biol. Pharm. Bull., 16:223-227; 1993.
Suzuki, T., Ohno, N., et al: &qu
